4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-023524
President and CEO acquired 111,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SCANGOS GEORGE A · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-10 | Grant or award : show line 1 in the form | +111,000 | 223,989 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-10 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +222,000 | 222,000 | D |
Loading xslF345X03/doc4.xml…